United States · Venture startup

Who invested in PluroGen Therapeutics

4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

PharmaManufacturing

Follow PluroGen Therapeutics and see its new rounds in your feed. Start following

Funding summaryUpdated 7 Nov 2026

$3.4Mraised across 4 rounds since 2007, from 4 sources

$1.7MSeed$1.2MSeries B$300KSeries B$153KVenture

Latest round: Venture, $153KApr 2014
Biggest round: $1.7MSeed · Apr 2007
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072008200920102011201220132014

$1.7MSeed$1.2MSeries B$300KSeries B$153KVenture

First round: Seed, $1.7M
Biggest round: $1.7M
Usual gap between rounds: 2.2 years

The rounds

Apr 2014
Venture$153K
No investor was named in the report.
From a historical funding recordSEC filing: $153K sold, first sale Apr 2014
Jan 2014
Series B$300K
No investor was named in the report.
From a historical funding recordSEC filing: $300K sold, first sale Dec 2013
Nov 2011
Series B$1.2M
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Nov 2011
Apr 2007
Seed$1.7M3 new
- Virginia Investment Capital Group, Inc.
- Cato BioVentures
- Jefferson Corner Group
Reported by plurogen.com

Funding filed with regulators

PluroGen Therapeutics filed 5 raises, $1.8M in all. Filings say how much was sold and to how many investors; they never name the investors.

Apr 2014$153K3 investorsequityof $3.5M offeredSEC Form D
Dec 2013$300K4 investorsequity, options, otherof $4.1M offeredSEC Form D
Oct 2013$75K2 investorsoptions, otherof $3.5M offeredSEC Form D
Nov 2011$1.2M2 investorsequity, options, otherof $3.0M offeredSEC Form D
Oct 2010$10K1 investordebt, optionsof $1.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 3 on the team.

Adam J. KatzExecutive Officer, Directori
George T. RodeheaverExecutive Officer, Directori
Neal G KollerExecutive Officer, Directori

On the board, as filediDaniel B. BrodyJames B. Farinholt

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2007Series B2011Series B2014Venture2014Virginia Investment Capital Group, Inc.Cato BioVenturesJefferson Corner Group

Everyone who backed them

Virginia Investment Capital Group, Inc.Angel network1round

Cato BioVenturesno record of our own yet1round

Jefferson Corner Groupno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about PluroGen Therapeutics

Who invested in PluroGen Therapeutics?

PluroGen Therapeutics's investors include Virginia Investment Capital Group, Inc., Cato BioVentures and Jefferson Corner Group.

How much has PluroGen Therapeutics raised?

PluroGen Therapeutics has raised $3.4M across 4 rounds since 2007.

When did PluroGen Therapeutics last raise?

PluroGen Therapeutics's most recent round was a Venture of $153K in Apr 2014.

What was PluroGen Therapeutics's biggest round?

PluroGen Therapeutics's largest round on record is $1.7M (Seed), in Apr 2007.

Who backed PluroGen Therapeutics first?

PluroGen Therapeutics's first round on record, in Apr 2007, was backed by Virginia Investment Capital Group, Inc., Cato BioVentures and Jefferson Corner Group.